Atrás
Rango del Día
$21.61
$23.06
Rango de 52 Semanas
$11.43
$31.04
Volumen
3,188,999
Promedio 50D / 200D
$17.68
/
$19.87
Cierre Anterior
$23.17
Quick Summary
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (627 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -1.9 | 0.3 |
| P/B | 1.1 | 3.0 |
| ROE % | -43.9 | 3.7 |
| Net Margin % | -33.3 | 3.8 |
| Rev Growth 5Y % | 9.4 | 10.0 |
| D/E | 1.4 | 0.2 |
Precio Objetivo de Analistas
Hold
$19.82
-12.6%
Low: $14.00
High: $25.00
P/E Futuro
15.32
EPS Futuro
$1.51
Crecimiento EPS (est.)
+0.0%
Ingresos Est.
3.41B
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2029 |
$1.83
$1.80 – $1.87
|
4.20B | 1 |
| FY2028 |
$1.88
$1.84 – $1.92
|
3.82B | 2 |
| FY2027 |
$1.72
$1.61 – $1.96
|
3.61B | 7 |
No quarterly estimates available
Dividend History
Yield
0.00%
Payout Ratio
N/A
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Puntos Clave
Revenue grew 9.38% annually over 5 years — modest growth
Earnings declined -531.42% over the past year
Negative free cash flow of -439.91M
PEG of 0.00 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 4.34%
Crecimiento
Revenue Growth (5Y)
9.38%
Revenue (1Y)5.04%
Earnings (1Y)-531.42%
FCF Growth (3Y)N/A
Calidad
Return on Equity
-43.91%
ROIC6.32%
Net Margin-33.29%
Op. Margin11.71%
Seguridad
Debt / Equity
1.36
Current Ratio1.55
Interest Coverage2.79
Valoración
P/E Ratio
-1.90
Forward P/EN/A
P/B Ratio1.07
EV/EBITDA11.89
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 5.04% | Revenue Growth (3Y) | 6.35% |
| Earnings Growth (1Y) | -531.42% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 9.38% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 3.31B | Net Income (TTM) | -1.10B |
| ROE | -43.91% | ROA | -19.95% |
| Gross Margin | 17.61% | Operating Margin | 11.71% |
| Net Margin | -33.29% | Free Cash Flow (TTM) | -439.91M |
| ROIC | 6.32% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 1.36 | Current Ratio | 1.55 |
| Interest Coverage | 2.79 | ||
| Dividends | |||
| Dividend Yield | 0.00% | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -1.90 | Forward P/E | N/A |
| P/B Ratio | 1.07 | P/S Ratio | 0.63 |
| PEG Ratio | 0.00 | Forward PEG | N/A |
| EV/EBITDA | 11.89 | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -21.03% | ||
| Market Cap | 2.09B | Enterprise Value | 4.61B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 3.31B | 3.15B | 2.93B | 2.61B | 2.31B |
| Net Income | -1.10B | 255.61M | -21.67M | 273.14M | 190.64M |
| EPS (Diluted) | -12.16 | 2.78 | -0.24 | 2.98 | 2.10 |
| Gross Profit | 583.44M | 711.98M | 682.61M | 2.51B | 2.22B |
| Operating Income | 387.97M | 522.28M | 506.60M | 467.70M | 414.47M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 5.53B | 5.96B | 5.36B | 4.99B | 4.77B |
| Total Liabilities | 3.39B | 2.77B | 2.47B | 2.09B | 2.19B |
| Shareholders' Equity | 1.95B | 3.07B | 2.78B | 2.81B | 2.52B |
| Total Debt | 2.65B | 2.09B | 1.51B | 1.53B | 1.64B |
| Cash & Equivalents | 133.24M | 76.31M | 100.07M | 97.65M | 133.81M |
| Current Assets | 814.14M | 577.49M | 596.00M | 506.13M | 495.03M |
| Current Liabilities | 525.19M | 577.92M | 885.78M | 388.33M | 404.86M |